Kindred Biosciences Inc
KIN·Stocks·Pharmaceuticals Major·United States·Nasdaq·USD
Price
$6.35
Today
+0.0%
YTD
+0.0%
About
Kindred Biosciences is a healthcare firm that develops biologics for pets. The firm was founded in 2012 and has many novel biologics in development. Headquartered in Burlingame, California, the company operates within the US. Kindred Biosciences trades on the NASDAQ CM under the ticker KIN. Stay up-to-date on the KIN share price by listing it on your eToro watchlist.
Price chart
Closing price history for KIN (1D candles).
Open positions
Current open positions for this instrument from your live portfolio.
Open positions
0
Unrealized return
+0.0%
No open positions exist for this instrument at the moment.
Financial insights
Valuation
P/E (TTM)-9.02
P/S (TTM)Unknown
P/B (TTM)5.27
Market cap$420.53M
Cap tierSmall-cap
Industry avg P/E-7.40
Profitability
Gross margin14.88%
EBIT margin-497.34%
Net margin-258.07%
ROE-50.36%
ROA-37.32%
Earnings & Revenue
Revenue (TTM)$7.93M
Revenue growth (1Y)-81.4%
EPS (TTM)-$1.03
Free cash flow$-30.09M
Total debt$23.23M
Dividends & Risk
Dividend rate$0.00
Dividend yield0.00%
Beta (5Y)1.17
Employees63
Next earnings9 Nov '21
Trade history
Closed trades
0
Realized return
+0.0%
No stored closed trades exist for this instrument yet.